Gm2 Gangliosidosis Stocks List
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IBRN | D | iShares Neuroscience and Healthcare ETF | 0.63 | |
PTH | C | Invesco DWA Healthcare Momentum ETF | 0.43 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.41 | |
IWC | C | iShares Microcap ETF | 0.09 | |
IBBQ | D | Invesco Nasdaq Biotechnology ETF | 0.04 |
Compare ETFs
Related Industries:
Biotechnology
- Gm2 Gangliosidosis
Gm2 Gangliosidosis is a rare, inherited disorder caused by a deficiency of an enzyme called beta-hexosaminidase. This enzyme is responsible for breaking down certain fatty substances in the body called gangliosides. When the enzyme is deficient, these fatty substances accumulate in the brain and other organs, leading to a variety of neurological and physical symptoms. Symptoms of Gm2 Gangliosidosis can include seizures, developmental delays, muscle weakness, vision and hearing loss, and difficulty swallowing.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles